Tobacco smoking cessation management: integrating varenicline in current practice

Laurence M GalantiClinique Universitaire UCL, Mont-Godinne, Yvoir, BelgiumAbstract: Tobacco smoking is widespread and is one of the world’s most prevalent modifiable risk factors for morbidity and mortality. It is important to facilitate smoking cessation better in order to reduce the heal...

Full description

Bibliographic Details
Main Author: Laurence M Galanti
Format: Article
Language:English
Published: Dove Medical Press 2008-08-01
Series:Vascular Health and Risk Management
Subjects:
Online Access:https://www.dovepress.com/tobacco-smoking-cessation-management-integrating-varenicline-in-curren-peer-reviewed-article-VHRM
id doaj-27997a8e082f4349839e038b01d3594b
record_format Article
spelling doaj-27997a8e082f4349839e038b01d3594b2020-11-24T20:41:33ZengDove Medical PressVascular Health and Risk Management1178-20482008-08-01Volume 48378452171Tobacco smoking cessation management: integrating varenicline in current practiceLaurence M GalantiLaurence M GalantiClinique Universitaire UCL, Mont-Godinne, Yvoir, BelgiumAbstract: Tobacco smoking is widespread and is one of the world’s most prevalent modifiable risk factors for morbidity and mortality. It is important to facilitate smoking cessation better in order to reduce the health consequences of tobacco use. The most effective approach assisting smokers in their quit attempts combines both pharmacotherapy and nonpharmacological interventions. This review summarizes the latest international epidemiological data available on tobacco use, considers the associated effects on health, and reviews existing policies against tobacco use. Among the interventions for smoking cessation, the three major pharmacotherapies (which have demonstrated efficacy when combined with behavioral support) are discussed: nicotine replacement therapy (NRT), bupropion, and varenicline. As the newest pharmacotherapy made available in this area, particular consideration is given to varenicline, and a review of our clinical experience is offered.Keywords: tobacco smoking cessation, nicotinic substitution, nicotine replacement therapy (NRT), bupropion, vareniclinehttps://www.dovepress.com/tobacco-smoking-cessation-management-integrating-varenicline-in-curren-peer-reviewed-article-VHRMtobacco smoking cessationnicotinic substitutionnicotine replacement therapy (NRT)bupropionvarenicline
collection DOAJ
language English
format Article
sources DOAJ
author Laurence M Galanti
spellingShingle Laurence M Galanti
Tobacco smoking cessation management: integrating varenicline in current practice
Vascular Health and Risk Management
tobacco smoking cessation
nicotinic substitution
nicotine replacement therapy (NRT)
bupropion
varenicline
author_facet Laurence M Galanti
author_sort Laurence M Galanti
title Tobacco smoking cessation management: integrating varenicline in current practice
title_short Tobacco smoking cessation management: integrating varenicline in current practice
title_full Tobacco smoking cessation management: integrating varenicline in current practice
title_fullStr Tobacco smoking cessation management: integrating varenicline in current practice
title_full_unstemmed Tobacco smoking cessation management: integrating varenicline in current practice
title_sort tobacco smoking cessation management: integrating varenicline in current practice
publisher Dove Medical Press
series Vascular Health and Risk Management
issn 1178-2048
publishDate 2008-08-01
description Laurence M GalantiClinique Universitaire UCL, Mont-Godinne, Yvoir, BelgiumAbstract: Tobacco smoking is widespread and is one of the world’s most prevalent modifiable risk factors for morbidity and mortality. It is important to facilitate smoking cessation better in order to reduce the health consequences of tobacco use. The most effective approach assisting smokers in their quit attempts combines both pharmacotherapy and nonpharmacological interventions. This review summarizes the latest international epidemiological data available on tobacco use, considers the associated effects on health, and reviews existing policies against tobacco use. Among the interventions for smoking cessation, the three major pharmacotherapies (which have demonstrated efficacy when combined with behavioral support) are discussed: nicotine replacement therapy (NRT), bupropion, and varenicline. As the newest pharmacotherapy made available in this area, particular consideration is given to varenicline, and a review of our clinical experience is offered.Keywords: tobacco smoking cessation, nicotinic substitution, nicotine replacement therapy (NRT), bupropion, varenicline
topic tobacco smoking cessation
nicotinic substitution
nicotine replacement therapy (NRT)
bupropion
varenicline
url https://www.dovepress.com/tobacco-smoking-cessation-management-integrating-varenicline-in-curren-peer-reviewed-article-VHRM
work_keys_str_mv AT laurencemgalanti tobaccosmokingcessationmanagementintegratingvareniclineincurrentpractice
_version_ 1716824667831926784